UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2024 » Volume 32, issue 4 (121) » PSYCHOTHERAPY TACTICS FOR MENTAL DISORDERS AFTER SUFFERING FROM THE COVID-19 CORONAVIRUS DISEASE

PSYCHOTHERAPY TACTICS FOR MENTAL DISORDERS AFTER SUFFERING FROM THE COVID-19 CORONAVIRUS DISEASE

Authors

Type of Article

  • Scientific Article

In the Section

  • diagnosis and treatment of mental and behavioral disorders.

Key words

Index UDK:
  • 616.89-052:616.9-071-08

Abstract

The COVID-19 pandemic causes numerous physical and mental consequences that significantly worsen the health and social functioning of the population. It has been established that a wide range of mental disorders (anxiety and depressive disorders, post-traumatic stress disorders, eating disorders) and psychological disorders (stress reactions, sadness, feelings of isolation) are developing under the influence of the COVID-19 pandemic. The COVID-19 pandemic causes numerous physical and mental consequences that significantly worsen the health and social functioning of the population.

The purpose of the study: development of complex psychotherapy for mental disorders due to the transferred coronavirus disease COVID-19.

The study included 63 cases with mental disorders after a cardiac infection of COVID-19. The diagnosis was made according to the ICD-10 criteria: mood disorders (affective disorders) (F32.0 — F32.2) — 34 patients, neurotic, stress-related and somatoform disorders (F40 — F45) — 32 patients, other mental disorders caused by the injury or brain dysfunction or as a result of somatic disease (F06.3 — F06.6) — 31 patients.

The data obtained as a result of the study indicate that as a result of the coronavirus disease COVID-19, various mental disorders occur within the limits of neurotic, stress-related and somatoform disorders, affective disorders and mental disorders of organic origin. Mental disorders due to the coronavirus disease COVID-19 are characterized by a complex of changes in the mental state and psychological instructions, which significantly worsens the condition of patients. Such changes include not only clinical and psychopathological symptoms, but also pathological changes in coping strategies, the level of adaptability, frustration tolerance and quality of life. Also, a complex of psychotraumatic factors, which complicates the course of mental disorders, makes a significant contribution to the course of the disorder. All this requires a complex specific approach to the therapy of mental disorders due to the coronavirus disease COVID-19, which should include both pharmacotherapy and psychotherapy. Pharmacotherapy is prescribed taking into account the dominant clinical symptoms. Thus, with the severity of depressive symptoms, antidepressants from the group of selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors are prescribed; with the severity of an alarming symptom complex — anxiolytics. In addition, it is advisable to use general strengthening drugs and, if necessary, vascular drugs. The data obtained as a result of the study indicate that as a result of the coronavirus disease COVID-19, various mental disorders occur within the limits of neurotic, stress-related and somatoform disorders, affective disorders and mental disorders of organic origin. Mental disorders due to the coronavirus disease COVID-19 are characterized by a complex of changes in the mental state and psychological instructions, which significantly worsens the condition of patients. Such changes include not only clinical and psychopathological symptoms, but also pathological changes in coping strategies, the level of adaptability, frustration tolerance and quality of life. Also, a complex of psychotraumatic factors, which complicates the course of mental disorders, makes a significant contribution to the course of the disorder. All this requires a complex specific approach to the therapy of mental disorders due to the coronavirus disease COVID-19, which should include both pharmacotherapy and psychotherapy. Pharmacotherapy is prescribed taking into account the dominant clinical symptoms. Thus, with the severity of depressive symptoms, antidepressants from the group of selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors are prescribed; with the severity of an alarming symptom complex — anxiolytics. In addition, it is advisable to use general strengthening drugs and, if necessary, vascular drugs.

The data obtained as a result of the study indicate that as a result of the coronavirus disease COVID-19, various mental disorders occur within the limits of neurotic, stress-related and somatoform disorders, affective disorders and mental disorders of organic origin. Mental disorders due to the coronavirus disease COVID-19 are characterized by a complex of changes in the mental state and psychological instructions, which significantly worsens the condition of patients. Such changes include not only clinical and psychopathological symptoms, but also pathological changes in coping strategies, the level of adaptability, frustration tolerance and quality of life. Also, a complex of psychotraumatic factors, which complicates the course of mental disorders, makes a significant contribution to the course of the disorder. All this requires a complex specific approach to the therapy of mental disorders due to the coronavirus disease COVID-19, which should include both pharmacotherapy and psychotherapy. Pharmacotherapy is prescribed taking into account the dominant clinical symptoms. Thus, with the severity of depressive symptoms, antidepressants from the group of selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors are prescribed; with the severity of an alarming symptom complex — anxiolytics. In addition, it is advisable to use general strengthening drugs and, if necessary, vascular drugs. The data obtained as a result of the study indicate that as a result of the coronavirus disease COVID-19, various mental disorders occur within the limits of neurotic, stress-related and somatoform disorders, affective disorders and mental disorders of organic origin. Mental disorders due to the coronavirus disease COVID-19 are characterized by a complex of changes in the mental state and psychological instructions, which significantly worsens the condition of patients. Such changes include not only clinical and psychopathological symptoms, but also pathological changes in coping strategies, the level of adaptability, frustration tolerance and quality of life. Also, a complex of psychotraumatic factors, which complicates the course of mental disorders, makes a significant contribution to the course of the disorder. All this requires a complex specific approach to the therapy of mental disorders due to the coronavirus disease COVID-19, which should include both pharmacotherapy and psychotherapy. Pharmacotherapy is prescribed taking into account the dominant clinical symptoms. Thus, with the severity of depressive symptoms, antidepressants from the group of selective serotonin reuptake inhibitors or selective serotonin and norepinephrine reuptake inhibitors are prescribed; with the severity of an alarming symptom complex — anxiolytics. In addition, it is advisable to use general strengthening drugs and, if necessary, vascular drugs.

Pages

  • 14-22

Year / Issue

Download PDF

References

  1. World Health Organization. COVID-19 Weekly Epidemiological Update. (2023). URI: https://www.who.int/publications/m/ item/weekly-epidemiological-update-on-COVID-19—17-august-2023 (accessed March 19, 2023).
  2. Eissazade N, Shalbafan M, Saeed F, Hemmati D, Askari S, Sayed Mirramazani M, et al. The impact of the COVID-19 pandemic on Iranian psychiatric trainees’ and early career psychiatrists’ well-being, work conditions, and education. Acad Psychiatry. (2022) 46:710–7. DOI: https://doi.org/10.1007/s40596-022-01674-5.
  3. Xu X, Zhang J, Fang R, Liu H, Zhou W, She Y, et al. Evaluation of the mental health status of community frontline medical workers after the normalized management of COVID-19 in Sichuan, China. Front Psychiatry.  (2023) 14:1198822. DOI: https://doi.org/10.3389/fpsyt.2023.1198822.
  4. Adiukwu F, Kamalzadeh L, Pinto da Costa M, Ransing R, de Filippis R, Pereira-Sanchez V, et al. The grief experience during the COVID-19 pandemic across different cultures. Ann Gen Psychiatry. (2022) 21:18.  DOI: https://doi.org/10.1186/s12991-022-00397-z.
  5. Ullah I, Khan KS, Ali I, Ullah AR, Mukhtar S, de Filippis R, et al. Depression and anxiety among Pakistani healthcare workers amid COVID-19 pandemic: a qualitative study. Ann Med Surg. (2022) 78:103863. DOI: https://doi.org/10.1016/j.amsu.2022.103863.
  6. Ashiq MAR, Gupta PS, Jubayer Biswas MAA, Ahmed N, Sultana MstS, Ghosh B, et al. Depression, anxiety, stress, and fear of COVID-19 among Bangladeshi medical students during the first wave of the pandemic: a mixed-methods study. Front Psychiatry. (2023) 14:1142724.  DOI: https://doi.org/10.3389/fpsyt.2023.1142724.
  7. Anteneh RM, Dessie AM, Azanaw MM, Anley DT, Melese BD, Feleke SF, et  al. The  psychological impact of  COVID-19 pandemic and associated factors among college and university students in Ethiopia: a systematic review and meta-analysis, 2022. Front Public Health. (2023) 11:1136031. DOI: https://doi.org/10.3389/ fpubh.2023.1136031.
  8. Zenba Y, Kobayashi A, Imai T. Psychological distress is affected by fear of COVID-19 via lifestyle disruption and leisure restriction among older adults in  Japan: a  cross-sectional study. Front Public Health. (2023) 11:1264088. DOI: https://doi.org/10.3389/ fpubh.2023.1264088.
  9. Tahmasebi S, Khosh E, Esmaeilzadeh A. The outlook for diagnostic purposes of the 2019-novel coronavirus disease. J Cell Physiol. (2020) 235:9211–29.  DOI: https://doi.org/10.1002/jcp.29804.
  10. World Health Organization. #HealthyAtHome – Mental Health. URI: https://www.who.int/campaigns/connecting-theworld-to-combat-coronavirus/healthyathome/healthyathome– -mental-health (accessed March 19, 2023).
  11. Jones EAK, Mitra AK, Bhuiyan AR. Impact of COVID-19 on mental health in adolescents: a systematic review. Int J Environ Res Public Health. (2021) 18:2470.  DOI: https://doi.org/10.3390/ijerph18052470.
  12. Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. (2020) 9:636.  DOI: https://doi.org/10.12688/f1000research.24457.1.
  13. Guessoum SB, Lachal J, Radjack R, Carretier E, Minassian S, Benoit L, Moro MR. Adolescent psychiatric disorders during the COVID-19 pandemic and lockdown. Psychiatry Res. (2020) 291:113264.  DOI: https://doi.org/10.1016/j.psychres.2020.113264.
  14. Singh S, Roy D, Sinha K, Parveen S, Sharma G, Joshi G. Impact of COVID-19 and lockdown on mental health of children and adolescents: a narrative review with recommendations. Psychiatry Res. (2020) 293:113429.  DOI: https://doi.org/10.1016/j.psychres.2020.113429.
  15. Nalbandian A., Sehgal K., Gupta et  al. Post-acute COVID-19 syndrome. Nat Med. 2021. Vol. 27. P. 601–615.  DOI: https://doi.org/10.1038/s41591-021-01283-z.
  16. Witthöft, M., & Hiller, W. (2010). Psychological approaches to origins and treatments of somatoform disorders. Annual Review of Clinical Psychology, 6(1), 257–283. DOI: https://doi.org/10.1146/annurev.clinpsy.121208.131505.
  17. Ingman, T., Smakowski, A., Goldsmith, K., & Chalder, T. (2022). A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome. Psychological Medicine, 52(14), 2917– 2929. DOI: https://doi.org/10.1017/S0033291722002471.
  18. Kleinstäuber, M., Allwang, C., Bailer, J., Berking, M., Brünahl, C., Erkic, M., … Rief, W. (2019). Cognitive behaviour therapy complemented with emotion regulation training for patients with persistent physical symptoms: A  randomised clinical trial. Psychotherapy and Psychosomatics, 88(5), 287–299. DOI: https://doi.org/10.1159/000501621.
  19. Price, J. R., Mitchell, E., Tidy, E., & Hunot, V. (2008). Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database of Systematic Reviews,  3:CD001027. DOI: https://doi.org/10.1002/14651858.CD001027.pub2.
  20. Van Dessel, N., den Boeft, M., van der Wouden, J. C., Kleinstäuber, M., Leone, S. S., Terluin, B., … van Marwijk, H. W. (2014). Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUP in adults. Cochrane Database of Systematic Reviews, 11, CD011142. DOI: https://doi.org/10.1002/14651858.CD011142.pub2.
  21. Copyright of the work: Questionnaire for patients with mental disorders who have suffered from coronavirus disease COVID-19 and have been exposed to the stressors of the SARS-COV-2 pandemic / N. Maruta, V. Fedchenko, I. Yavdak, T. V. Panko, O. E. Semikina; application from 13.03.2023 c202301564; certificate from 11.04.2023 № 118009. O., Fedchenko V. Iu., Yavdak I. O., Panko T. V., Semikina O. Ie. [Copyright of the work: Questionnaire for patients with mental disorders who have experienced the coronavirus disease COVID-19 and were exposed to the stressors of the SARS-COV-2 pandemic]; application dated March 13, 2023 p202301564; certificate dated April 11, 2023 No. 118009.
  22. Velichkovsky B. B. Multidimensional assessment of individual resistance to stress // Bulletin of Moscow State Regional University. 2007. № 3. С. 105-112. / Velichkovskiy B. B. [Multidimensional assessment of individual resistance to stress]. [Bulletin of Moscow State Regional University]. 2007. No. 3. P. 105-112. (In Russian).
  23. Multilevel personality questionnaire "Adaptability" (MLO-AM) by A. G. Maklakov and S. V. Chermianin. V. Chermyanin. Practical psychodiagnostics. Methods and tests : a textbook / ed. and compiled by. Raigorodsky D. Ya. Samara, 2006. С. 549-672. / [Multilevel personality questionnaire "Adaptability" (MLO-AM) by A. G. Maklakov and S. V. Chermyanin. Practical psychodiagnostics. Methods and tests]: a tutorial / ed. and compiled by Raigorodsky D. Ya. Ya. Samara, 2006. Pp. 549-672. (In Russian).

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»